Showing 131-140 of 3101 results for "".
Multiple Sclerosis in Context: Psychological Comorbidities and Adverse Health Behaviors
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-context-psychological-comorbidities-and-adverse-health-behaviors/30521/Adult-Onset Cerebellar Ataxias
https://practicalneurology.com/diseases-diagnoses/movement-disorders/adult-onset-cerebellar-ataxias/31221/Pravin Khemani, MD, Medical Director, Movement Disorders Program, Swedish Neuroscience Institute, provides a framework for evaluation of adult-onset cerebellar ataxias.ELEVATE (Qulipta for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments; NCT04740827)
https://practicalneurology.com/programs/practical-neurology/elevate-qulipta-for-prophylaxis-of-migraine-in-participants-who-failed-previous-oral-prophylactic-treatments-nct04740827/31255/Patricia Pozo-Rosich, MD, PhD, Headache Specialist from the Vall d’Hebron University Hospital in Barcelona, Spain, provides an overview of the ELEVATE clinical trial.A Mark of Success?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-mark-of-success/31075/Achim Schneeberger, MD, talks about the Phase II study that demonstrated clinical and biomarker effects consistent with disease modification in Alzheimer's. (headphones recommended)Advances in the Evaluation of TBI
https://practicalneurology.com/diseases-diagnoses/tbi/advances-in-the-evaluation-of-tbi/30093/Welcome to Neurology: Disease Deep Dive. In this episode, Dr. Beth McQuiston, MD, RD, Medical Director at Abbott Laboratories, and Dr. David Okonkwo, MD, PhD, Professor of Neurological Surgery, Clinical Director of the Brain Trauma Research Center, and Director of the Neurotrauma Program at UniversiProgressive Multiple Sclerosis: Functional, Anatomic, and Biologic Tools to Assess Disability Progression and Improve Patient Outcomes
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/progressive-multiple-sclerosis-functional-anatomic-and-biologic-tools-to-assess-disability-progression-and-improve-patient-outcomes/33143/An enhanced ability to quantify multiple sclerosis disease progression is key for timely optimization of treatment and risk mitigation of worsening disability.Multiple Sclerosis—The Truth Lies Within Us
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosisthe-truth-lies-within-us/30300/Data presented at the recent ECTRIMS offer fresh insight and potentially new direction into the cause of multiple sclerosis.The Central Vein Sign
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-central-vein-sign/31627/Is 1.5 T MRI still relevant for diagnosis of multiple sclerosis?Case Report: AntiNMDA Receptor Encephalitis
https://practicalneurology.com/diseases-diagnoses/imaging-testing/case-report-antinmda-receptor-encephalitis/31760/In these cases, 2 women with ovarian teratomas leading to autoimmune encephalitis, had markedly different outcomes.Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.